KATHERINE BLALOCK: Open Payments
NPI 1639771330 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,454 in 84 payments from 23 companies in 2025. Trend: 2023 $1,836 · 2024 $3,923 · 2025 $2,454
Food & beverage: $2,454
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $518 |
| AstraZeneca Pharmaceuticals LP | 17 | $514 |
| GENZYME CORPORATION | 8 | $255 |
| JAZZ PHARMACEUTICALS INC. | 3 | $177 |
| Insmed, Inc. | 7 | $144 |
| Lilly USA, LLC | 2 | $137 |
| Phathom Pharmaceuticals, Inc. | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 5 | $95 |
| United Therapeutics Corporation | 3 | $81 |
| Verona Pharma, Inc. | 4 | $80 |
Products named: DUPIXENT, AREXVY, XYWAV, TRELEGY ELLIPTA, Arikayce, ZEPBOUND, TEZSPIRE, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
